Cavernous Malformation
Understanding Cavernous Malformation (Cavernoma, Cavernous Hemangioma) diagnosis, symptoms, and treatment options. Find information on Cavernous Malformation ICD-10 codes, clinical documentation best practices, and healthcare coding guidelines for accurate medical record keeping. Learn about Cavernoma differential diagnosis and explore resources for patients and medical professionals dealing with Cavernous Hemangioma.
A cluster of abnormal blood vessels, usually in the brain or spinal cord.
Headaches, seizures, neurological deficits (weakness, numbness, vision changes). Often asymptomatic.
Neurology, Neurosurgery, diagnostic imaging centers (MRI, CT scan).
ICD-10 Code Families
Complete code families applicable to D18.02
When to use each related code
| Description | When to use |
|---|---|
| Vascular malformation with mulberry-like appearance. | Use for well-defined, mulberry-like lesions on imaging. Consider Cavernoma and Cavernous Hemangioma as synonyms. |
| Dilated capillary cluster, often with slow blood flow. | Use for capillary malformations, often seen as port-wine stains. Distinguish from cavernous malformations. |
| Tangle of abnormal arteries and veins, lacking capillaries. | Use for arteriovenous malformations (AVMs), characterized by direct arterial-venous shunting. |
Best-practice checklist
- ✓Document lesion size and location (e.g., 8mm left temporal lobe)
- ✓Describe symptoms (e.g., seizures, headaches, focal deficits)
- ✓Note any hemorrhage (e.g., microbleed, macrohemorrhage)
- ✓Record family history of cavernous malformations
- ✓Specify diagnostic method (e.g., MRI, CT, angiography)
Common pitfalls to avoid
ICD-10 coding for cavernous malformation requires laterality (right, left, bilateral) and intracranial vs. spinal location for accurate reimbursement.
Clinical documentation must clearly differentiate between cavernous malformation, hemangioma, and other vascular anomalies for proper code assignment (e.g., I77.0 vs. D18.0).
If active bleeding is present, accurate coding requires specifying both the cavernous malformation and the hemorrhage (e.g., I60.0, I77.0) to reflect the acuity.
Best-practice tips
- 01Regular MRI for size/symptom monitoring (ICD-10 I67.0)
- 02Neuro assessment, document bleed/neuro deficit (CPT 99202-99215)
- 03Control hypertension to reduce hemorrhage risk (ICD-10 I10)
- 04Surgical resection for accessible symptomatic lesions (CPT 61680)
- 05Genetic counseling for familial cases (ICD-10 Q87.8)
Step-by-step checklist
- 1
Confirm characteristic MRI findings: popcorn-like appearance.
- 2
Rule out other vascular malformations: AVMs, angiomas.
- 3
Assess for neurological symptoms: seizures, headaches, focal deficits.
- 4
Consider genetic testing if family history is present.
- 5
Document diagnosis using ICD-10 code I67.0: Cavernous malformation
Ready-to-paste narrative
Patient presents with signs and symptoms suggestive of a cavernous malformation, also known as a cavernoma or cavernous hemangioma. Presenting complaints include [Insert patient's specific symptoms, e.g., headaches, seizures, focal neurological deficits, hemorrhage]. Differential diagnosis includes other cerebrovascular malformations such as arteriovenous malformations (AVMs), capillary telangiectasias, and venous angiomas. Diagnostic workup included [Insert imaging modalities used, e.g., MRI brain with and without contrast, CT scan, cerebral angiography] which revealed a characteristic popcorn-like appearance consistent with a cavernous malformation located in the [Specify location, e.g., left temporal lobe, brainstem, spinal cord]. The lesion measures [Insert lesion size] and demonstrates [Describe imaging characteristics, e.g., a well-defined border, hemosiderin staining, associated edema]. Clinical correlation supports the diagnosis of cavernous malformation. Treatment options including conservative management with symptomatic treatment, microsurgical resection, and stereotactic radiosurgery were discussed with the patient. The risks and benefits of each approach were explained, and the patient elected [State chosen treatment plan]. Follow-up [Specify follow-up plan, e.g., neurological examination, repeat imaging] is scheduled to monitor for any changes in the lesion and manage potential complications such as recurrent hemorrhage, seizure activity, or neurological decline. ICD-10 code I78.0 (Cavernous hemangioma) is documented for billing and coding purposes. Patient education was provided regarding cavernous malformation symptoms, prognosis, and the importance of adherence to the treatment plan.
Common questions and answers
What are the key radiological features differentiating a cavernous malformation (cavernoma) from other intracranial vascular lesions on MRI?+
Cavernous malformations exhibit characteristic radiological features on MRI that help distinguish them from other vascular lesions like capillary telangiectasias, arteriovenous malformations, and venous angiomas. A classic cavernoma appears as a well-circumscribed "popcorn-like" lesion with a mixed signal intensity core due to varying stages of hemorrhage. The surrounding hemosiderin rim, a consequence of previous bleeding, is a crucial diagnostic clue, often appearing as a low signal intensity on both T1- and T2-weighted images. Unlike arteriovenous malformations, cavernomas typically lack associated flow voids or feeding arteries. Gradient echo sequences are particularly sensitive for detecting the small amounts of blood products characteristic of cavernomas. However, in some cases, particularly smaller or non-bleeding lesions, the appearance can be less distinct, requiring careful evaluation and correlation with clinical presentation. Consider implementing advanced MRI techniques like susceptibility-weighted imaging (SWI) for improved detection of small or occult cavernomas. Explore how SWI can enhance your diagnostic accuracy in challenging cases.
When is surgical resection indicated for patients with asymptomatic cavernous malformations (cavernomas), and what factors influence this decision?+
While many patients with cavernous malformations remain asymptomatic and may be managed conservatively with observation, surgical resection is sometimes considered even in the absence of symptoms. This decision is complex and influenced by several factors, including lesion location, size, and bleeding history. Deep-seated cavernomas in eloquent brain regions, such as the brainstem or basal ganglia, carry a higher risk of significant neurological deficits if they bleed and may warrant surgical removal even if asymptomatic. Similarly, a history of prior hemorrhage from a cavernoma, even if it was clinically silent or minor, increases the risk of future bleeding and may favor surgical intervention. Lesion size is also a consideration, with larger cavernomas generally posing a higher risk. Ultimately, the decision to pursue surgery for an asymptomatic cavernoma requires a careful risk-benefit assessment based on individual patient factors and shared decision-making between the patient, neurosurgeon, and neurologist. Learn more about the latest guidelines for managing asymptomatic cavernomas to optimize patient outcomes.
What are the best practices for long-term follow-up and surveillance of patients with incidentally discovered cavernous malformations (cavernous hemangiomas)?+
Patients with incidentally discovered cavernous malformations require individualized long-term follow-up and surveillance strategies depending on their specific characteristics and risk factors. Initial imaging with MRI, often including gradient echo or SWI sequences, is essential for accurate characterization of the lesion. For asymptomatic patients with small, stable cavernomas in non-eloquent brain regions, annual or biennial MRI follow-up may be sufficient. However, patients with larger lesions, those located in eloquent areas, or those with a history of bleeding may require more frequent imaging, potentially every 6-12 months. Clinical follow-up with a neurologist is also important to monitor for new or worsening symptoms, such as headaches, seizures, or focal neurological deficits. Patient education regarding potential symptoms and the importance of prompt medical attention if they occur is crucial. Explore how incorporating genetic counseling into the management of familial cavernomas can provide valuable insights for patients and their families. Consider implementing standardized surveillance protocols to ensure consistent and optimal care for patients with cavernous malformations.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.